Patent · US Active

Device comprising a hydrogel having a glucose-binding protein and a ligand of the glucose-binding protein incorporated therein

US10429380B2 · kind B2 · utility

0Cited by

2References

22Claims

0Family size

Assignee

EYESENSE GMBH · CH

Inventors

Achim Müller · Aschaffenburg, DE
Peter Herbrechtsmeier · Königstein, DE
Monika Knuth · Goldbach, DE
Katharina Nikolaus · Aschaffenburg, DE

Key dates

Filing date	Dec 13, 2011
Grant date	Oct 1, 2019
Priority date	—
Expiry date	Sep 3, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/66
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to measures for determining glucose and for diagnosing diseases based on impaired glucose metabolism. In particular the present invention relates to a device comprising a hydrogel having a glucose-binding protein and a ligand of the glucose-binding protein incorporated therein, wherein the hydrogel comprises a first hydrogel matrix made of alginate and a second hydrogel matrix which forms an interpenetrating network within the first hydrogel matrix. The invention further relates to the use of such a device for determining the glucose content in a sample and to the use of the device for diagnosing impaired glucose metabolism in a test subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.